Delivery Order SPE2DR25D9225-SPE2DR26FFAY6
- Not listed
- The Defense Logistics Agency issued a $95,242.06 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, represents a routine pharmaceutical delivery under the agency's medical supply operations. DMS Pharmaceutical Group was selected...
- The Defense Logistics Agency awarded a delivery order valued at $79,695.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, issued on October 27, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery order falls...
- The Defense Logistics Agency has awarded a delivery order valued at $18,868.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $205,854.67 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 12, 2025. The delivery order covers Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units and is structured as a firm fixed-price contract with an ultimate completion date of September 15, 2025. This award does not utilize a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, awarded on June 4, 2025, with an ultimate completion date of June 5, 2025, was issued without a set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency issued a delivery order valued at $37,736.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $18,868.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order represents one of numerous purchase orders...
- The Defense Logistics Agency awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a discrete pharmaceutical fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Issued on November 6, 2025, with an ultimate completion date of November 7, 2025, this firm fixed-price delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- SPE2DR25D9225Indefinite Delivery Contract
- SPE2DR25D9225-SPE2DR26FFAY6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $94,763.11 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that enables DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc. has established itself as a critical pharmaceutical supplier within the federal military medical system, with substantial contracting activity concentrated through DLA's Medical Supply Chain division. The company maintains a diverse product portfolio spanning branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. As a single-award prime vendor contractor under the PPV-G GEN V program with a contract ceiling of $499,999,999 and completion date of December 31, 2036, DMS Pharmaceutical Group is positioned to serve as a regional supplier for recurring medical supply needs of military healthcare facilities. The company has demonstrated consistent performance across multiple therapeutic categories and delivery orders, with no identified subcontractor relationships in its award documentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $94.8k | 12/3/25 |